Status:
COMPLETED
To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment
Lead Sponsor:
Guilan University of Medical Sciences
Conditions:
Pelvic Inflammatory Disease
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
Objective: To compare two oral treatments: Ofloxacin + Metronidazole, and Azitromycin +Metronidazole in outpatients with Pelvic Inflammatory Disease. Materials and Methods: Two hundred patients divid...
Detailed Description
Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days,...
Eligibility Criteria
Inclusion
- Eligibility criteria were having three out of five following symptoms: a-lower abdominal pain, b-vaginal discharges, c- adnexal tenderness, d-cervical motion tenderness (CMT), e-cervisitis.
- \-
Exclusion
- Excluding criteria were as follows: a-unmarried women, b-pregnant women, c-women with infection during menstruation, d- history of abortion or miscarriage during the last month, e-underlying diseases such as diabetes, f-used antibiotics in the last month, or allergy to the antibiotics used in the study, g-history of Pelvic Inflammatory Disease within the last year, and h- suspicion of being multi partner.
- \-
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01241110
Start Date
January 1 2010
End Date
September 1 2010
Last Update
November 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alzahra Maternity Hospital
Rasht, Gilan Province, Iran, 16746